Abstract
In this population-based study, we evaluated the association between exposure to hormone therapy (HT), bone mineral density (BMD) and the prevalence of non-vertebral fractures. The study was set in a region located in southeastern Australia where complete fracture ascertainment was determined from radiological reports. Current HT use for at least 6 months was ascertained in women with non-vertebral fractures [median age 70.9 years; inter-quartile range (IQR) 66.5–75.9 years] and randomly selected controls (median age 70.8 years; IQR 65.2–75.0 years). Current HT use was documented in 20 of 262 cases and 49 of 364 controls. The odds ratio (OR) for non-vertebral fracture associated with HT use was 0.53 (95% CI 0.31–0.92). HT use was associated with 2.6–7.5% higher BMD at axial and appendicular sites. HT use is associated with a halving of risk for non-vertebral fractures and higher BMD.
Similar content being viewed by others
References
Rosen CJ, Kessenich CR (1997) The pathophysiology and treatment of postmenopausal osteoporosis: an evidence-based approach to estrogen replacement therapy. Endocrinol Metab Clin North Am 26:295–311
Hutchinson TA, Polansky SM, Feinstein AR (1979) Post-menopausal estrogens protect against fractures of hip and distal radius: a case-control study. Lancet 2:705–709
Weiss NS, Ure CL, Ballard JH, Williams AR, Daling JR (1980) Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med 303:1195–1198
Paganini-Hill A, Ross RK, Gerkins VR, Henderson BE, Arthur M, Mack TM (1981) Menopausal estrogen therapy and hip fractures. Ann Intern Med 95:28–31
Ettinger B, Genant HK, Cann CE (1985) Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102:319–324
Kiel DP, Felson DT, Anderson JJ, Wilson PW, Moskowitz MA (1987) Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. N Engl J Med 317:1169–1174
Cauley JA, Seeley DG, Ensrud K, Ettinger B, Black D, Cummings SR (1995) Estrogen replacement therapy and fractures in older women. Study of Osteoporotic Fractures Research Group. Ann Intern Med 122:9–16
Rossouw JE, Anderson GL, Prentice RL et al (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333
Pasco JA, Sanders KM, Henry MJ, Nicholson GC, Seeman E, Kotowicz MA (2000) Calcium intakes among Australian women: Geelong Osteoporosis Study. Aust N Z J Med 30:21–27
Henry MJ, Pasco JA, Nicholson GC, Seeman E, Kotowicz MA (2000) Prevalence of osteoporosis in Australian women: Geelong Osteoporosis Study. J Clin Densitom 3:261–268
Ross K (1984) The Developement of the 1984 indicator of socio-economic disadvantage. Deakin University, Geelong, Victoria, Australia
Sanders KM, Seeman E, Ugoni AM et al. (1999) Age- and gender-specific rate of fractures in Australia: a population-based study. Osteoporos Int 10:240–247
Pasco JA, Henry MJ, Gaudry TM, Nicholson GC, Kotowicz MA (1999) Identification of incident fractures: the Geelong Osteoporosis Study. Aust N Z J Med 29:203–206
Mazess RB, Barden H (1999) Bone density of the spine and femur in adult white females. Calcif Tissue Int 65:91–99
Lohman T, Roche A, Martorell R (1988) Anthropometric standardization reference manual. Human Kinetics Books, Champaign, Illinois
Grady D, Rubin SM, Petitti DB et al. (1992) Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117:1016–1037
Komulainen MH, Kroger H, Tuppurainen MT et al. (1998) HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women: a 5-year randomized trial. Maturitas 31:45–54
Mosekilde L, Beck-Nielsen H, Sorensen OH et al. (2000) Hormonal replacement therapy reduces forearm fracture incidence in recent postmenopausal women: results of the Danish Osteoporosis Prevention Study. Maturitas 36:181–193
Cauley JA, Black DM, Barrett-Connor E et al. (2001) Effects of hormone replacement therapy on clinical fractures and height loss: the Heart and Estrogen/Progestin Replacement Study (HERS). Am J Med 110:442–450
Lufkin EG, Wahner HW, O’Fallon WM et al. (1992) Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med 117:1–9
Wells G, Tugwell P, Shea B et al. (2002) Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocrinol Rev 23:529–539
Torgerson DJ, Bell-Syer SE (2001) Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 285:2891–2897
Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PW, Anderson JJ (1993) The effect of postmenopausal estrogen therapy on bone density in elderly women. N Engl J Med 329:1141–1146
The writing group for the PEPI (1996) Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen/Progestin Interventions (PEPI) trial. JAMA 276:1389–1396
Speroff L, Rowan J, Symons J, Genant H, Wilborn W (1996) The comparative effect on bone density, endometrium, and lipids of continuous hormones as replacement therapy (CHART Study): a randomized controlled trial. JAMA 276:1397–1403
Naessen T, Lindmark B, Larsen HC (1997) Better postural balance in elderly women receiving estrogens. Am J Obstet Gynecol 177:412–416
Randell KM, Honkanen RJ, Komulainen MH, Tuppurainen MT, Kroger H, Saarikoski S (2001) Hormone replacement therapy and risk of falling in early postmenopausal women: a population-based study. Clin Endocrinol (Oxf) 54:769–774
Hoidrup S, Gronbaek M, Pederson AT, Lauritzen JB, Gottschau A, Schroll M (1999) Hormone replacement therapy and hip fracture risk: effect modification by tobacco smoking, alcohol intake, physical activity, and body mass index. Am J Epidemiol 150:1085–1093
Acknowledgements
The study was funded by the Victorian Health Promotion Foundation and the Geelong Region Medical Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pasco, J.A., Kotowicz, M.A., Henry, M.J. et al. Hormone therapy and risk of non-vertebral fracture: Geelong Osteoporosis Study. Osteoporos Int 15, 434–438 (2004). https://doi.org/10.1007/s00198-003-1574-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00198-003-1574-1